Antimicrobial Susceptibility of Bacterial Pathogens from Patients with Ocular Surface Infections in Germany, 2020-2021: A Comparison with the Data from Three Previous National Studies

Antibiotics (Basel). 2024 May 21;13(6):471. doi: 10.3390/antibiotics13060471.

Abstract

Bacteria are a major cause of superficial eye infections, especially in children. The present study aimed to (i) determine the antimicrobial susceptibility patterns of ocular bacterial pathogens recovered in 20 laboratories during the period 2020-2021 and (ii) compare these results to those from three studies of the same design conducted in 2004, 2009, and 2015 in Germany. Cut-off values defined by EUCAST were used as breakpoints. A total of 1366 bacterial isolates were collected. The most frequent ocular specimens were conjunctival smears (54.3%). Susceptibility rates of Staphylococcus aureus (n = 594), Haemophilus influenzae (n = 178), and Streptococcus pneumoniae (n = 149) to chloramphenicol, gentamicin, kanamycin, neomycin, levofloxacin, ofloxacin, and oxytetracycline were >90% each. Overall, only minor changes in resistance levels were observed in the period since 2004. Therefore, all tested antimicrobials can still be recommended for local therapy of ocular surface infections.

Keywords: ocular surface infections; ophthalmic drugs; susceptibility testing; topical agents.

Grants and funding

This work was supported by grants from Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH, mibe GmbH Arzneimittel, OmniVision GmbH, ratiopharm GmbH, Santen SAS, Ursapharm Arzneimittel GmbH, and Devatis GmbH.